SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR. 2025;3(1):522-531. Accessed April 30, 2025. http://www.thermsr.com/index.php/Journal/article/view/403